These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38476028)

  • 1. Transfusion-related errors and associated adverse reactions and blood product wastage as reported to the National Healthcare Safety Network Hemovigilance Module, 2014-2022.
    Chavez Ortiz JL; Griffin I; Kazakova SV; Stewart PB; Kracalik I; Basavaraju SV
    Transfusion; 2024 Apr; 64(4):627-637. PubMed ID: 38476028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
    Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How is national recipient hemovigilance conducted in the United States?
    Chung KW; Harvey A; Basavaraju SV; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):703-7. PubMed ID: 25565577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
    Mowla SJ; Kracalik IT; Sapiano MRP; O'Hearn L; Andrzejewski C; Basavaraju SV
    Transfus Med Rev; 2021 Apr; 35(2):78-84. PubMed ID: 33934903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
    Edens C; Haass KA; Cumming M; Osinski A; O'Hearn L; Passanisi K; Eaton L; Visintainer P; Savinkina A; Kuehnert MJ; Basavaraju SV; Andrzejewski C
    Transfusion; 2019 Feb; 59(2):524-533. PubMed ID: 30427540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network.
    Cumming M; Osinski A; O'Hearn L; Waksmonski P; Herman M; Gordon D; Griffiths E; Knox K; McHale E; Quillen K; Rios J; Pisciotto P; Uhl L; DeMaria A; Andrzejewski C
    Transfusion; 2017 Feb; 57(2):478-483. PubMed ID: 27774608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion reaction reporting in the era of hemovigilance: where form meets function.
    Dunbar NM; Walsh SJ; Maynard KJ; Szczepiorkowski ZM
    Transfusion; 2011 Dec; 51(12):2583-7. PubMed ID: 21745209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do we use the National Healthcare Safety Network for Hemovigilance in Massachusetts?
    Iannone A; Cumming M; Osinski A; Brandeburg C; Schultz J; Slider A; Rodrigue B; O'Hearn L; Herman M; McHale E; Rios J; Uhl L; Andrzejewski C; DeMaria A
    Transfusion; 2024 Feb; 64(2):200-209. PubMed ID: 38158876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
    Dhiman Y; Raturi M; Kala M; Kusum A
    Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events of red blood cell transfusions in patients with sickle cell disease.
    Rollins MR; Chou ST
    Transfus Apher Sci; 2022 Oct; 61(5):103557. PubMed ID: 36064527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction in the French hemovigilance system.
    Rieux C; Brittenham G; Bachir D; De Meyer E; Boudjedir K;
    Transfus Clin Biol; 2019 May; 26(2):109-111. PubMed ID: 30910456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the early coronavirus disease 2019 pandemic on blood utilization in the United States: A time-series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module.
    Kracalik I; Mowla S; Katz L; Cumming M; Sapiano MRP; Basavaraju SV
    Transfusion; 2021 Sep; 61 Suppl 2(Suppl 2):S36-S43. PubMed ID: 33990963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System.
    Kasraian L; Karimi MH
    Hemoglobin; 2015; 39(4):274-80. PubMed ID: 26036919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety incident reports associated with blood transfusions.
    Vossoughi S; Perez G; Whitaker BI; Fung MK; Rajbhandary S; Crews N; Stotler B
    Transfusion; 2019 Sep; 59(9):2827-2832. PubMed ID: 31254465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of transfusion quality indicators as a tool for hemovigilance system implementation at a tertiary care center in Saudi Arabia.
    Hindawi SI; Badawi MA; Raj ET; Gholam KA; Al-Weail SO; Azher F
    Saudi Med J; 2016 May; 37(5):538-43. PubMed ID: 27146617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposing a Model for the National Hemovigilance Information System in Iran.
    Asadi F; Ramezanghorbani N
    J Med Life; 2020; 13(2):211-218. PubMed ID: 32742516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
    Oakley FD; Woods M; Arnold S; Young PP
    Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.